Stem Cell Therapy For Copd Clinical Trials

Remestemcel l mesoblast s lead candidate stem cell therapy for inflammatory diseases improves lung function and exercise capacity in people with chronic obstructive pulmonary disease copd and a high degree of inflammation data from a post hoc analysis of a phase 2 trial show.

Stem cell therapy for copd clinical trials.

There have already been successes in treating blood related diseases with stem cells derived from the blood. A study to assess the effectiveness safety and tolerability of dupilumab in patients with moderate to severe chronic obstructive pulmonary disease copd with type 2 inflammation. The food and drug administration fda hasn t approved any stem cell treatments for people with copd and clinical trials haven t advanced beyond phase ii. Phase ii is where researchers try.

The patient s cells and platelet rich plasma are harvested through venous or bone marrow collection techniques. But research is progressing and more clinical trials are being developed each year. Findings were presented in an oral presentation at the 2020 international society for cell gene therapy isct. Learn more about copd clinical trials around the world.

5 on the other hand the results have been quite mixed when using stem cell therapy for other diseases especially copd.